Thomas Civik - 16 Nov 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role: Director
Signature: /s/ Steve Forte, Attorney-in-Fact
Issuer symbol: RPTX
Transactions as of: 16 Nov 2021
Transactions value $: $210,600
Form type: 4
Filing time: 18 Nov 2021, 16:00:49 UTC
Previous filing: 07 Oct 2021
Next filing: 19 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPTX	Common Shares	Purchase	$210,600	+7,500		$28.08	7,500	16 Nov 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.50 to $28.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.50 to $28.19 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.